These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10480633)

  • 1. Partial resistance to infection by R5X4 primary HIV type 1 isolates in an exposed-uninfected individual homozygous for CCR5 32-base pair deletion.
    Xiao L; Weiss SH; Qari SH; Rudolph D; Zhao C; Denny TN; Hodge T; Lal RB
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1201-8. PubMed ID: 10480633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.
    Agrawal L; Lu X; Qingwen J; VanHorn-Ali Z; Nicolescu IV; McDermott DH; Murphy PM; Alkhatib G
    J Virol; 2004 Mar; 78(5):2277-87. PubMed ID: 14963124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
    Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
    Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB
    Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.
    Ostrowski MA; Justement SJ; Catanzaro A; Hallahan CA; Ehler LA; Mizell SB; Kumar PN; Mican JA; Chun TW; Fauci AS
    J Immunol; 1998 Sep; 161(6):3195-201. PubMed ID: 9743388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.
    Quillent C; Oberlin E; Braun J; Rousset D; Gonzalez-Canali G; Métais P; Montagnier L; Virelizier JL; Arenzana-Seisdedos F; Beretta A
    Lancet; 1998 Jan; 351(9095):14-8. PubMed ID: 9433423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.
    Gorry PR; Zhang C; Wu S; Kunstman K; Trachtenberg E; Phair J; Wolinsky S; Gabuzda D
    Lancet; 2002 May; 359(9320):1832-4. PubMed ID: 12044382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
    Sáez-Cirión A; Versmisse P; Truong LX; Chakrabarti LA; Carpentier W; Barré-Sinoussi F; Scott-Algara D; Pancino G
    Retrovirology; 2006 Nov; 3():81. PubMed ID: 17092330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32.
    Michael NL; Nelson JA; KewalRamani VN; Chang G; O'Brien SJ; Mascola JR; Volsky B; Louder M; White GC; Littman DR; Swanstrom R; O'Brien TR
    J Virol; 1998 Jul; 72(7):6040-7. PubMed ID: 9621067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
    Joly M; Pinto JM
    Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coreceptor requirements of primary HIV type 1 group O isolates from Cameroon.
    Dittmar MT; Zekeng L; Kaptue L; Eberle J; Kräusslich HG; Gürtler L
    AIDS Res Hum Retroviruses; 1999 May; 15(8):707-12. PubMed ID: 10357466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of alternative coreceptor use by pediatric HIV-1 R5 isolates for infection of primary cord or adult peripheral blood mononuclear cells.
    Sullivan WM; Dorr P; Perros M; Hudson R; Leif J; Luzuriaga K; Clapham PR
    Arch Virol; 2008; 153(2):363-6. PubMed ID: 18074097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
    Bunnik EM; Quakkelaar ED; van Nuenen AC; Boeser-Nunnink B; Schuitemaker H
    J Virol; 2007 Jan; 81(2):525-31. PubMed ID: 17079299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the CCR5 coding and noncoding regions among HIV type 1-exposed, persistently seronegative female sex-workers from Thailand.
    Yang C; Li M; Limpakarnjanarat K; Young NL; Hodge T; Butera ST; McNicholl JM; Mastro TD; Lal RB
    AIDS Res Hum Retroviruses; 2003 Aug; 19(8):661-5. PubMed ID: 13678468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.